These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4269798)

  • 1. [Antisera to fibrinogen degradation products, fragments D and E].
    Sudo T; Fujisawa M; Okumura H; Manita H
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):652-3. PubMed ID: 4269798
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental study of rabbit fibrinogen degradation products. Influence of plasminogen level for the interpretation of serum concentration of fibrinogen degradation products in consumption coagulopathies.
    Soria J; Soria C; Vairel E; Prost RJ; Warneson G
    Thromb Diath Haemorrh; 1973 Feb; 29(1):115-21. PubMed ID: 4267735
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of a polyacrylamide gel gradient for the separation of fibrinogen degradation products. Sensitivity of the immunological reaction of hemagglutination inhibition. Merskey's test on various isolated fragments].
    Soria J; Fabiani P
    Ann Biol Clin (Paris); 1971; 29(4):303-7. PubMed ID: 4257050
    [No Abstract]   [Full Text] [Related]  

  • 4. The structure of the fibrinogen degradation products.
    Marder VJ; Budzynski AZ
    Prog Hemost Thromb; 1974; 2(0):141-74. PubMed ID: 4137300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Assay methods and significance of fibrin-fibrinogen degradation products in blood].
    Shinada S
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):607-16. PubMed ID: 4677376
    [No Abstract]   [Full Text] [Related]  

  • 6. An accelerated red-cell hemagglutination inhibition immunoassay for measuring fibrinogen degradation products in human serum.
    Fischer R; Furlan M; Beck EA
    Thromb Diath Haemorrh; 1971 Oct; 26(2):311-4. PubMed ID: 5167423
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen breakdown products: identification and assay in serum and urine.
    Rayner H; Parashevas F; Israels LG; Israels ED
    J Lab Clin Med; 1969 Oct; 74(4):586-96. PubMed ID: 4241717
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.
    Plow E; Edgington TS
    J Clin Invest; 1973 Feb; 52(2):273-82. PubMed ID: 4119160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific anti-human fibrinogen immune serum. Methods of preparation and specificity determination].
    Ionescu-Stoian F; Ionescu-Dorohoi T; Zilişteanu C
    Arch Roum Pathol Exp Microbiol; 1971; 30(3):449-62. PubMed ID: 5150507
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen degradation products: a critical study of two assay methods.
    Thuot C; Larrieu MJ
    Rev Eur Etud Clin Biol; 1971; 16(1):27-34. PubMed ID: 4252113
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinogen and fibrin degradation products].
    Fujimaki M; Ikematsu S; Kato M
    Rinsho Byori; 1973 Jan; 21(1):31-6. PubMed ID: 4267650
    [No Abstract]   [Full Text] [Related]  

  • 12. Degradation of fibrinogen in vitro. Demonstration of several antigenic intermediates by specific anti-D and anti-E serum.
    Gormsen J; Feddersen C; Clemmensen I; Andersen RB
    Scand J Haematol; 1972; 9(6):577-86. PubMed ID: 4118846
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiation of fibrinogen degradation products (FDP) in plasma by precipitation with polyethylene glycol.
    Zubler RH; Lambert PH; Miescher PA
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1367-8. PubMed ID: 4213874
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid detection of fibrinogen-related antigens in serum.
    Rabaa MS; Bernier GM; Ratnoff OD
    J Lab Clin Med; 1973 Mar; 81(3):476-83. PubMed ID: 4119816
    [No Abstract]   [Full Text] [Related]  

  • 15. Release of fibrinopeptides from fibrinolytic fibrinogen fragment E.
    Peyer A; Straub PW
    Thromb Diath Haemorrh; 1973 May; 29(2):300-12. PubMed ID: 4271587
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
    Chi DS; Chen JP
    Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative study of adult and fetal sheep fibrinogen, sulf-fibrinogen and fibrinogen degradation products.
    Loly W; Israels LG; Bishop AJ; Israels ED
    Thromb Diath Haemorrh; 1971 Dec; 26(3):526-40. PubMed ID: 4259443
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitation of plasma fibrinogen in the presence of fibrinogen degradation products.
    Arnesen H
    Scand J Haematol; 1973; 11(3):204-9. PubMed ID: 4797270
    [No Abstract]   [Full Text] [Related]  

  • 20. Degradation of human fibrinogen by Brinastrase, trypsin and chymotrypsin. An immunological study.
    Gormsen J; Feddersen C; Andersen RB
    Scand J Haematol; 1973; 10(5):349-57. PubMed ID: 4272383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.